Asbestos exposure, pleural plaques, and the risk of death from lung cancer

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 12, 2014, Pages 1413-1420

  Pairon, Jean Claude ^a,b,c   Andujar, Pascal ^a,b,c   Rinaldo, Mickael ^d,e,f   Ameille, Jacques ^g   Brochard, Patrick ^d,e,f   Chamming's, Soizick ^g   Clin, Bénédicte ^h,i,j   Ferretti, Gilbert ^d,k,l   Gislard, Antoine ^m   Laurent, Francois ^e,f,n   Luc, Amandine ^o,p   Wild, Pascal ^o,q   Paris, Christophe ^o,p,r  

^a INSERM U955   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^d INSERM   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f BORDEAUX UNIVERSITY HOSPITAL   (France)

^g Institut Interuniversitaire   (France)

^h Axe 2: 'Biology and Innovative Therapeutics for Locally Aggressive Cancers'   (France)

ⁱ CAEN UNIVERSITY HOSPITAL   (France)

^j UNIVERSITÉ DE CAEN   (France)

^k UNIV GRENOBLE ALPES   (France)

^l GRENOBLE UNIVERSITY HOSPITAL   (France)

^m ROUEN UNIVERSITY HOSPITAL   (France)

ⁿ CENTRE DE RECHERCHE CARDIO THORACIQUE DE BORDEAUX   (France)

^o EA7298 INGRES   (France)

^p UNIVERSITY HOSPITAL OF NANCY   (France)

^q INSTITUT NATIONAL DE RECHERCHE ET DE SÉCURITÉ   (France)

^r UNIVERSITÉ DE LORRAINE   (France)

more..

Author keywords

Asbestos; CT scan; Lung cancer; Pleural plaques; Screening

Indexed keywords

ASBESTOS;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; ENVIRONMENTAL EXPOSURE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; IMAGE ANALYSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PLEURA PLAQUE; RISK FACTOR; SMOKING; CHEMICALLY INDUCED; LUNG TUMOR; MASS SCREENING; MIDDLE AGED; MORTALITY; OCCUPATIONAL EXPOSURE; PLEURA; PLEURA DISEASE; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY;

ASBESTOS; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PLEURA; PLEURAL DISEASES; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84919372704     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201406-1074OC     Document Type: Article

References (41)

1. American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med 2004;170: 691-715.
2. Prazakova S, Thomas PS, Sandrini A, Yates DH. Asbestos and the lung in the 21st century: An update. Clin Respir J 2014;8: 1-10.
3. Weiss W. Asbestosis: A marker for the increased risk of lung cancer among workers exposed to asbestos. Chest 1999;115: 536-549.
4. Hillerdal G, Henderson DW. Asbestos, asbestosis, pleural plaques and lung cancer. Scand J Work Environ Health 1997;23: 93-103.
5. Reid A, de Klerk N, Ambrosini GL, Olsen N, Pang SC, Berry G, Musk AW. The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone. Occup Environ Med 2005;62: 885-889.
6. Banks DE, Shi R, McLarty J, Cowl CT, Smith D, Tarlo SM, Daroowalla F, Balmes J, Baumann M. American College of Chest Physicians consensus statement on the respiratory health effects of asbestos. Results of a Delphi study. Chest 2009;135: 1619-1627.
7. Hillerdal G. Pleural plaques and risk for bronchial carcinoma and mesothelioma. A prospective study. Chest 1994;105: 144-150.
8. Karjalainen A, Pukkala E, Kauppinen T, Partanen T. Incidence of cancer among Finnish patients with asbestos-related pulmonary or pleural fibrosis. Cancer Causes Control 1999;10: 51-57.
9. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365: 395-409.
10. Jaklitsch MT, Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, MacMahon H, Mulshine JL, Munden RF, Salgia R, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012;144: 33-38.
11. Moyer VA; U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160: 330-338.
12. Ollier M Jr, Chamoux A, Naughton G, Pereira B, Dutheil F. Chest CT scan screening for lung cancer in asbestos occupational exposure: A systematic review and meta-Analysis. Chest 2014;145: 1339-1346.
13. Paris C, Thierry S, Brochard P, Letourneux M, Schorle E, Stoufflet A, Ameille J, Conso F, Pairon JC; National APEXS Members. Pleural plaques and asbestosis: Dose-And time-response relationships based on HRCT data. Eur Respir J 2009;34: 72-79.
14. Consensus development conference for the elaboration of a clinical medical surveillance strategy for people exposed to asbestos. Paris, France, 15 January 1999 [in French]. Rev Mal Respir 1999;16: 1187-1362.
15. Pairon JC, Laurent F, Rinaldo M, Clin B, Andujar P, Ameille J, Brochard P, Chammings S, Ferretti G, Galateau-SalléF, et al. Pleural plaques and the risk of pleural mesothelioma. J Natl Cancer Inst 2013;105: 293-301.
16. Pairon JC, Laurent F, Ameille J, Brochard P, Chamming's S, Clin B, Ferretti G, Gislard A, Letourneux M, Luc A, SchorléE, Paris C. Pleural plaques and the risk of lung cancer in a French cohort of asbestos-exposed subjects. Presented at the European Respiratory Society Congress 2013. September 2013, Barcelona, Spain. Eur Respir J 2013;42: 1910.
17. Pairon JC, Clin B, Laurent F, Ameille J, Brochard P, Gislard A, Luc A, Wild P, Paris C. Are subjects with pleural plaques at increased risk of lung cancer? Preliminary findings from the French Asbestos Related Diseases Cohort (ARDCO) program. Presented at the International Conference on Monitoring and Surveillance of Asbestos-related Diseases 2014. February 11-13, 2014, Espoo, Finland.
18. Ameille J, Letourneux M, Paris C, Brochard P, Stoufflet A, Schorle E, Gislard A, Laurent F, Conso F, Pairon JC. Does asbestos exposure cause airway obstruction, in the absence of confirmed asbestosis? Am J Respir Crit Care Med 2010;182: 526-530.
19. Clin B, Paris C, Ameille J, Brochard P, Conso F, Gislard A, Laurent F, Letourneux M, Luc A, Schorle E, et al. Do asbestos-related pleural plaques on HRCT scans cause restrictive impairment in the absence of pulmonary fibrosis? Thorax 2011;66: 985-991.
20. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: Glossary of terms for thoracic imaging. Radiology 2008;246: 697-722.
21. Beigelman-Aubry C, Ferretti G, Mompoint D, Ameille J, Letourneux M, Frija J, Laurent F. Computed tomographic atlas of benign asbestos related pathology [in French]. J Radiol 2007;88: 845-862.
22. Mackenbach JP, Kunst AE, Lautenbach H, Oei YB, Bijlsma F. Gains in life expectancy after elimination of major causes of death: Revised estimates taking into account the effect of competing causes. J Epidemiol Community Health 1999;53: 32-37.
23. Marcus PM, Gareen IF, Miller AB, Rosenbaum J, Keating K, Aberle DR, Berg CD. The National Lung Screening Trial's Endpoint Verification Process: Determining the cause of death. Contemp Clin Trials 2011; 32: 834-840.
24. Clin B, Luc A, Morlais F, Paris C, Ameille J, Brochard P, De Girolamo J, Gislard A, Laurent F, Letourneux M, et al.; National Network of Asbestos Post-Exposure Survey (APEXS). Pulmonary nodules detected by thoracic computed tomography scan after exposure to asbestos: Diagnostic significance. Int J Tuberc Lung Dis 2011;15: 1707-1714.
25. Cullen MR, Barnett MJ, Balmes JR, Cartmel B, Redlich CA, Brodkin CA, Barnhart S, Rosenstock L, Goodman GE, Hammar SP, et al. Predictors of lung cancer among asbestos-exposed men in the b-carotene and retinol efficacy trial. Am J Epidemiol 2005;161: 260-270.
26. Aberle DR, Balmes JR. Computed tomography of asbestos-related pulmonary parenchymal and pleural diseases. Clin Chest Med 1991; 12: 115-131.
27. Ameille J, Brochard P, Letourneux M, Paris C, Pairon JC. Asbestosrelated cancer risk in patients with asbestosis or pleural plaques. Rev Mal Respir 2011;28: E11-e17.
28. Das M, Mühlenbruch G, Mahnken AH, Hering KG, Sirbu H, Zschiesche W, Knoll L, Felten MK, Kraus T, Günther RW, et al. Asbestos Surveillance Program Aachen (ASPA): Initial results from baseline screening for lung cancer in asbestos-exposed high-risk individuals using low-dose multidetector-row CT. Eur Radiol 2007;17: 1193-1199.
29. Mastrangelo G, Ballarin MN, Bellini E, Bizzotto R, Zannol F, Gioffre F, Gobbi M, Tessadri G, Marchiori L, Marangi G, et al. Feasibility of a screening programme for lung cancer in former asbestos workers. Occup Med (Lond) 2008;58: 175-180.
30. Tiitola M, Kivisaari L, Huuskonen MS, Mattson K, Koskinen H, Lehtola H, Zitting A, Vehmas T. Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer 2002; 35: 17-22.
31. Roberts HC, Patsios DA, Paul NS, DePerrot M, Teel W, Bayanati H, Shepherd F, Johnston MR. Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure. J Thorac Oncol 2009;4: 620-628.
32. Felten MK, Knoll L, Schikowsky C, Das M, Feldhaus C, Hering KG, B öcking A, Kraus T. Is it useful to combine sputum cytology and lowdose spiral computed tomography for early detection of lung cancer in formerly asbestos-exposed power industry workers? J Occup Med Toxicol 2014;9: 14.
33. Donaldson K, Murphy FA, Duffin R, Poland CA. Asbestos, carbon nanotubes and the pleural mesothelium: A review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2010;7: 5.
34. Heintz NH, Janssen-Heininger YM, Mossman BT. Asbestos, lung cancers, and mesotheliomas: From molecular approaches to targeting tumor survival pathways. Am J Respir Cell Mol Biol 2010; 42: 133-139.
35. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, et al. Benefits and harms of CT screening for lung cancer: A systematic review. JAMA 2012;307: 2418-2429.
36. Field JK, Oudkerk M, Pedersen JH, Duffy SW. Prospects for population screening and diagnosis of lung cancer. Lancet 2013;382: 732-741.
37. Manser R, Lethaby A, Irving LB, Stone C, Byrnes G, Abramson MJ, Campbell D. Screening for lung cancer. Cochrane Database Syst Rev 2013;6: CD001991.
38. Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, Zakher B, Fu R, Slatore CG. Screening for lung cancer with lowdose computed tomography: A systematic review to update the US Preventive services task force recommendation. Ann Intern Med 2013;159: 411-420.
39. Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, MacMahon H, Mulshine JL, Munden RF, Salgia R, Strauss GM, et al. Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: Recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. J Thorac Cardiovasc Surg 2012;144: 25-32.
40. Couraud S, Cortot AB, Greillier L, Gounant V, Mennecier B, Girard N, Besse B, Brouchet L, Castelnau O, FrappéP, et al.; French Lung Cancer Screening Statement Taskforce; Groupe d'Oncologie de Langue Française. From randomized trials to the clinic: Is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF). Ann Oncol 2013;24: 586-597.
41. de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, et al. Benefits and harms of computed tomography lung cancer screening strategies: A comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160: 311-320.